Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Oklahoma 23 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
PHASE3INTERVENTIONAL Oklahoma City, Oklahoma
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NAINTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
NAINTERVENTIONAL Oklahoma City, Oklahoma
RECRUITING
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
PHASE2INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type